CIK 0000921299
- Non-accelerated filer
- Smaller reporting company
KYNTRA BIO, INC.
Sign in to watch- Ticker
- KYNB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 770357827
- Phone
- +1 415-978-1200
- Business address
- 350 BAY STREET, SUITE 100 #6009, SAN FRANCISCO, CA, 94133
- Former names
- FIBROGEN INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-09-03 | Yu K Peony Chief Medical Officer | Exercise or conversion · Stock Option (Right to Buy) | −10,000 | 42,500 | ||
| 2020-09-03 | Cotroneo Pat SVP, Finance and CFO | Exercise or conversion | +637 | $29.66 | $19K | 278,947 |
| 2020-09-03 | Cotroneo Pat SVP, Finance and CFO | Exercise or conversion | +5,696 | $19.39 | $110K | 284,643 |
| 2020-09-03 | Cotroneo Pat SVP, Finance and CFO | Exercise or conversion | +8,671 | $25.40 | $220K | 293,314 |
| 2020-09-03 | Cotroneo Pat SVP, Finance and CFO | Sale | −15,004 | $50.91 | $764K | 278,310 |
| 2020-09-03 | Cotroneo Pat SVP, Finance and CFO | Exercise or conversion · Stock Option (Right to Buy) | −637 | 4,618 | ||
| 2020-09-03 | Cotroneo Pat SVP, Finance and CFO | Exercise or conversion · Stock Option (Right to Buy) | −5,696 | 0 | ||
| 2020-09-03 | Cotroneo Pat SVP, Finance and CFO | Exercise or conversion · Stock Option (Right to Buy) | −8,671 | 41,579 | ||
| 2020-08-20 | Schoeneck James A Director | Exercise or conversion | +6,000 | $5.95 | $36K | 15,400 |
| 2020-08-20 | Schoeneck James A Director | Exercise or conversion · Stock Option (Right to Buy) | −6,000 | 0 | ||
| 2020-08-11 | Cotroneo Pat SVP, Finance and CFO | Exercise or conversion | +3,750 | $19.39 | $73K | 274,810 |
| 2020-08-11 | Cotroneo Pat SVP, Finance and CFO | Exercise or conversion | +3,500 | $18.00 | $63K | 278,310 |
| 2020-08-11 | Cotroneo Pat SVP, Finance and CFO | Exercise or conversion · Stock Option (Right to Buy) | −3,750 | 5,696 | ||
| 2020-08-11 | Cotroneo Pat SVP, Finance and CFO | Exercise or conversion · Stock Option (Right to Buy) | −3,500 | 0 | ||
| 2020-08-07 | Cotroneo Pat SVP, Finance and CFO | Exercise or conversion | +22,554 | $19.39 | $437K | 293,614 |
| 2020-08-07 | Cotroneo Pat SVP, Finance and CFO | Sale | −22,554 | $48.00 | $1.1M | 271,060 |
| 2020-08-07 | Cotroneo Pat SVP, Finance and CFO | Exercise or conversion · Stock Option (Right to Buy) | −22,554 | 9,446 | ||
| 2020-08-05 | Cravatt Benjamin Director | Grant or award | +3,914 | 3,914 | ||
| 2020-08-05 | Cravatt Benjamin Director | Grant or award · Stock Option (Right to Buy) | +6,496 | 6,496 | ||
| 2020-08-05 | Cravatt Benjamin Director | Grant or award · Stock Option (Right to Buy) | +10,400 | 10,400 |
Page 19 of 33 · 651 trades